Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid SystemsLawrence Toll, Nurulain T. Zaveri, Michael R. Bruchas et al.|Pharmacological Reviews|2016Cited by 290
Activities of mixed NOP and μ‐opioid receptor ligandsBarbara Spagnolo, Nurulain T. Zaveri, Girolamo Calò et al.|British Journal of Pharmacology|2007Cited by 62
In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403Federica Ferrari, Nurulain T. Zaveri, Davide Malfacini et al.|Pharmacology Research & Perspectives|2017Cited by 31
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's diseaseLudovico Arcuri, Michele Morari, Riccardo Viaro et al.|Neurobiology of Disease|2016Cited by 29
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Girolamo Calò, Maria Camilla Cerlesi et al.|European Journal of Pharmacology|2016Cited by 21